IN RE: Generic Pharmaceuticals Pricing Antitrust Litigation

  1. February 01, 2024

    State-Led Generic Drug Cases Removed From MDL

    The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.

  2. April 07, 2017

    JPML Sends Generic Drug Price-Fixing Suits To Pennsylvania

    The Judicial Panel on Multidistrict Litigation on Thursday said the Eastern District of Pennsylvania is the best place to consolidate lawsuits accusing Mylan, Sandoz Inc. and other pharmaceutical companies of fixing prices on generic drugs, and expanded the case to include eight products instead of only two.